116 related articles for article (PubMed ID: 31989568)
1. Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.
Zhang L; Gao W; Keohavong P
Methods Mol Biol; 2020; 2102():373-394. PubMed ID: 31989568
[TBL] [Abstract][Full Text] [Related]
2. Analysis of K-RAS and P53 mutations in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2005; 291():217-33. PubMed ID: 15502226
[TBL] [Abstract][Full Text] [Related]
3. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
4. Detection of point mutations of K-ras oncogene and p53 tumor-suppressor gene in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2014; 1105():325-44. PubMed ID: 24623240
[TBL] [Abstract][Full Text] [Related]
5. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
6. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Thunnissen FB
Methods Mol Med; 2003; 75():305-23. PubMed ID: 12407749
[No Abstract] [Full Text] [Related]
7. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras and p53 mutations by "mutant-enriched" PCR-RFLP.
Schuermann M
Methods Mol Med; 2003; 75():325-33. PubMed ID: 12407750
[No Abstract] [Full Text] [Related]
9. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Pietersen AM; Theunissen PH; Thunnissen FB
J Clin Oncol; 1998 Sep; 16(9):3061-8. PubMed ID: 9738576
[TBL] [Abstract][Full Text] [Related]
11. Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples.
Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bertacca G; Merlo G; Bevilacqua G
Diagn Mol Pathol; 1997 Aug; 6(4):185-91. PubMed ID: 9360839
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao WM; Zheng KC; Mady HH; Melhem MF; Mumford JL
Carcinogenesis; 2005 Feb; 26(2):303-8. PubMed ID: 15564291
[TBL] [Abstract][Full Text] [Related]
13. Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer.
Zhang LF; Gao WM; Gealy R; Weissfeld J; Elder E; Whiteside TL; Keohavong P
Biomarkers; 2003; 8(2):156-61. PubMed ID: 12775500
[TBL] [Abstract][Full Text] [Related]
14. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
15. p53 and K-ras mutations in lung tissues and sputum samples of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao W
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():70-74. PubMed ID: 29704996
[TBL] [Abstract][Full Text] [Related]
16. Distribution of p53 and K-ras mutations in human lung cancer tissues.
Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
[TBL] [Abstract][Full Text] [Related]
19. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutation in sputum of patients with or without lung cancer.
Ronai Z; Yabubovskaya MS; Zhang E; Belitsky GA
J Cell Biochem Suppl; 1996; 25():172-6. PubMed ID: 9027615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]